The nation of Zimbabwe has declined a major American health deal worth $367m (£272m) over five years because of Washington's demand for sensitive data.
This move was revealed after a government memo dated December was disclosed, revealing that Head of State Emmerson Mnangagwa felt the deal was "skewed".
A government spokesperson has since clarified that the US was requesting biological samples for scientific study and profit while was unwilling to share the resulting advantages from future medical innovations.
"We will now turn to the difficult and regrettable task of winding down our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the US had donated more than $1.9bn for health programmes to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has urged more negotiations to secure a deal agreeable to both sides so the country's critical HIV programme can continue.
Broader Context
This development follows a comparable case in Kenya, where a high court halted a related health funding agreement after legal challenges were raised about the security of Kenyans' medical information.
After returning to the presidency last year, US President Donald Trump has drastically cut foreign aid and shut down the key foreign aid agency.
USAID had overseen assistance for the US government, but Trump stated its spending was "inefficient" and his government was pursuing government-to-government deals to boost transparency and responsibility.
As per statements, 16 African countries have so far agreed to similar health pacts, constituting over $18.3bn in committed funds.
Specifics of the Declined Deal
The funds for Zimbabwe was intended to gone towards "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this collaboration could have provided extraordinary advantages for the people of Zimbabwe, especially the 1.2 million men, women and children currently on antiretroviral therapy through US-supported programmes," the Ambassador commented.
However, official spokesman Nick Mangwana maintained the proposed deal was "asymmetrical".
"The proposal required Zimbabwe to share its genetic material and health information for a long time, without any corresponding promise of access to any scientific breakthroughs – such as new medicines or tests – that might result from that provided information," Mangwana explained.
"Put simply, our nation would provide the basic resources for scientific discovery with no assurance that the resulting innovations would be available to our population should a new pandemic emerge."
Sovereignty and International Frameworks
He also noted that the US's withdrawal from the global health body and its push of bilateral deals were undermining structures previously set up through the international organization.
Mangwana cited its Pandemic Benefit-Sharing scheme designed to deal with potential global health emergencies.
"This mechanism is intended to ensure that when a nation contributes its samples, the resulting advantages – including vaccines and treatments – are shared equitably, not monopolised solely by those with the funds to create them."
These objections over the US deal "are not meant as hostility towards the US," Mangwana stressed.
"We are open to further dialogue with our US partners on how subsequent collaboration might be structured in a way that respects the independence and interests of each country."
Health Experts Response
A leading public health body stated it recognised the official position, but urged that negotiations must proceed given that a large portion of the country's Aids initiatives were funded by international support.
"In cases where specific concerns arise, including those involving data governance or agreement terms, these can often be resolved through technical clarification and negotiated safeguards," it commented.
This impasse emphasises the continuing challenges between receiving vital international aid and protecting local interests in an ever more interconnected world.